Caspar da Cunha-Bang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Newly Diagnosed

Chronic Lymphocytic Leukemia

Prognostic Factors

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Brieghel, Caspar da Cunha-Bang, Jindrich Mourek, Lars Kjeldsen, Carsten Utoft Niemann
It is feasible and safe to stop specialized follow-up of asymptomatic lower-risk chronic lymphocytic leukemia. Blood advances 8 (16) (2024)
Christian Brieghel, Caspar da Cunha-Bang, Jindrich Mourek, Lars Kjeldsen, Carsten Utoft Niemann
It is feasible and safe to stop specialized follow-up of asymptomatic lower risk chronic lymphocytic leukemia. Blood advances (2024)
Rebecca Svanberg Teglgaard, Hanne Vibeke Hansen Marquart, Hans Jakob Hartling, Jakob Thaning Bay, Caspar da Cunha-Bang, Christian Brieghel, Tereza Faitová, Lisbeth Enggaard, Arnon P Kater, Mark-David Levin, Sabina Kersting, Sisse Rye Ostrowski, Carsten Utoft Niemann
Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Christian Brieghel, Caspar da Cunha-Bang, Jindrich Mourek, Lars Kjeldsen, Carsten Utoft Niemann
It is feasible and safe to stop specialized follow-up of asymptomatic lower-risk chronic lymphocytic leukemia. Blood advances 8 (16) (2024)
Rebecca Svanberg Teglgaard, Hanne Vibeke Hansen Marquart, Hans Jakob Hartling, Jakob Thaning Bay, Caspar da Cunha-Bang, Christian Brieghel, Tereza Faitová, Lisbeth Enggaard, Arnon P Kater, Mark-David Levin, Sabina Kersting, Sisse Rye Ostrowski, Carsten Utoft Niemann
Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Moritz Fürstenau, Yvonne J Thus, Sandra Robrecht, Clemens H M Mellink, Anne-Marie F van der Kevie-Kersemaekers, Julie Dubois, Julia von Tresckow, Michaela Patz, Michael Gregor, Patrick Thornton, Philipp Bernhard Staber, Tamar Tadmor, Mark-David Levin, Caspar da Cunha-Bang, Christof Schneider, Christian Bjørn Poulsen, Thomas Illmer, Björn Schöttker, Ann Janssens, Ilse Christiansen, Thomas Noesslinger, Michael Baumann, Holger Hebart, Tobias Gaska, Josien Regelink, Ellen C Dompeling, Vesa Lindstrom, Gunnar Juliusson, Anouk Andrea Widmer, Jeroen S Goede, Neta Goldschmidt, Florian Simon, Nisha De Silva, Anna Maria Fink, Kirsten Fischer, Clemens-Martin Wendtner, Matthias Ritgen, Monika Brüggemann, Eugen Tausch, Marcel Spaargaren, Eric Eldering, Stephan Stilgenbauer, Carsten Utoft Niemann, Michael Hallek, Barbara Eichhorst, Karl-Anton Kreuzer, Arnon P Kater
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations. Blood (2023)
Christian Brieghel, Veerle Galle, Rudi Agius, Caspar da Cunha-Bang, Michael Asger Andersen, Philip Vlummens, Mattias Mattsson, Richard Rosenquist, Karin E Smedby, Carmen D Herling, Jasmin Bahlo, Michael Hallek, Jens Dilling Lundgren, Fritz Offner, Carsten Utoft Niemann
Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait? European journal of haematology 108 (5) (2022)
Carsten Utoft Niemann, Caspar da Cunha-Bang, Marie Helleberg, Sisse R Ostrowski, Christian Brieghel
Patients with CLL have a lower risk of death from COVID-19 in the Omicron era. Blood 140 (5) (2022)
Caspar da Cunha-Bang, Klaus Rostgaard, Michael A Andersen, Emelie C Rotbain, Kirsten Grønbaek, Henrik Frederiksen, Carsten Utoft Niemann, Henrik Hjalgrim
Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study. British journal of haematology 193 (2) (2021)